Discovery & Development

Meet the analytical experts working at the cutting-edge of pharma analytics to ensure the safety of medicines.

A key focus of Andrew McLachlan’s career is understanding the impact of aging on drug disposition and response to medicines.

Drug delivery devices must take into account the needs of older adults.

The Medicine Maker speaks with Dr. Martin Klatt, Director Sales Pharma Solutions Europe from BASF

The color of a capsule or tablet can have a big impact on compliance and branding. To avoid delays, early decisions have to be made.

Douglas J. Swirsky, CEO of Rexahn Pharmaceuticals, explains his company’s approach to developing more effective cancer treatments.

The Medicine Maker speaks with Jeanne Thoma, President and CEO from SPI Pharma

In 2018, the UK’s government appointed its first Minister for Loneliness. The role: to tackle loneliness.

The Medicine Maker speaks with Christophe Le Ret, Global Marketing Director of Umicore

Sitting Down With… Steve Arlington, President at the Pistoia Alliance.